BI-0319

• Description:

  BI-0319 is a selective PTK2/FAK PROTAC degrader. BI-0319 can reduce cancer cells viability inhibit proliferation and invasion. BI-0319 can be used for the research of cancer, such as liver cancer[1][2]. (Structure Note: Pink: PTK2/FAK ligand (HY-43760) ; Blue: VHL ligand (HY-125845) ; Black: linker (HY-140189) ; VHL ligand-Linker: (HY-103602A) )

• UNSPSC:

  12352005

• Target:

  FAK; PROTACs

• Related Pathways:

  PROTAC; Protein Tyrosine Kinase/RTK

• Field of Research:

  Cancer

• Smiles:

  O=C1CCC2=CC=CC(OC3=NC(NC4=C(C=C(C=C4)C(NCCOCCOCCOCC(N[C@@H](C(C)(C)C)C(N5[C@@H](C[C@H](C5)O)C(NCC6=CC=C(C7=C(N=CS7)C)C=C6)=O)=O)=O)=O)OC)=NC=C3C(F)(F)F)=C21

• Molecular Formula:

  C52H59F3N8O11S

• Molecular Weight:

  1061.13

• References & Citations:

  [1]Popow J, et al. Highly Selective PTK2 Proteolysis Targeting Chimeras to Probe Focal Adhesion Kinase Scaffolding Functions. J Med Chem. 2019 Mar 14;62 (5) :2508-2520. |[2]Toffoli L, et al. FAK inhibition disrupts tumor growth, apoptosis, and transcriptional regulation in GI-NETs. Endocr Oncol. 2025 Aug 14;5 (1) :e250052.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [2341740-85-8]